Skip to main content
Molimo sačekajte...

ENDOKRINI ASPEKTI KRONOVE BOLEST

E-mail
sasa.ilic.dr@gmail.com
doctor@med.bg.ac.rs
vesnadsendo@gmail.com
srdjan.popovic@gmail.com
Ustanova
Klinika za endokrinologiju, dijabetes i bolesti metabolizma, Klinički centar Srbije
Reference
Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn's disease in adults. Am J Gastroenterol. 2018; 113(4): 481–517.
Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40(8): 955–962.
Peyrin-Biroulet L, Loft us EJ, Colombel J et al. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn’s disease in population-based cohorts. Infl Ann Bowel Dis. 2011; 17: 471–478.
Sažetak

ENDOKRINI ASPEKTI KRONOVE BOLEST

Medicinski glasnik

PROCENA RIZIKA ZA NASTANAK DIJABETESA TIP 2 USLOVLJENA NAVIKAMA U ISHRANI KOD ADOLESCENATA

Ustanova
Medicinski fakultet, Kragujevac
PMF, Novi Sad
Medicinska škola ’Dr Miša Pantić’, Valjevo
Reference
M. Dokić, M. Jevtić, D. Balać, Prevencija dijabetesa melitusa tipa 2 kod dece i adolescenata, Medicinski glasnik, 1452-09231141050D, 2011.
Ž. Lalić, К. Rašković, Procena rizika za dijabetes melitus tip 2 kod zdravstvenih radnika, Opšta medicina, UDC 616.379-008.64-05, 716(3-4);138–142, 2010.
Incidencija i mortalitet od dijabetesa u Srbiji, Institut za javno zdravlje „Milan Jovanović Batut, 2017.
Sažetak

PROCENA RIZIKA ZA NASTANAK DIJABETESA TIP 2 USLOVLJENA NAVIKAMA U ISHRANI KOD ADOLESCENATA

Medicinski glasnik

Inhibitor natrijum-glukoznog kotransportera tipa 2 – dapagliflozin u terapiji obolelih od diabetes mellitus tipa 2

E-mail
djenic.cigota@gmail.com
Ustanova
Zdravstveni centar Užice
Specijalna bolnica za bolesti štitaste žlezde i bolesti metabolizma Zlatibor
Reference
Đukić A, Đurđević P, Živančević-Simonović S, Jurišić V, Mijatović Lj. Opšta patološka fiziologija. Beograd; Intergraf: 2002; 400–408.
International Diabetes Federation. IDF Diabetes Atlas, 7th ed. International Diabetes Federation: Brussels, Belgium: 2015; available at: http://www.diabetesatlas.org
Stark Casagrande, S., Fradkin, J., Saydah, S., Rust, K. and Cowie, C. (2013) The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care 36: 2271–2279.
Sažetak

Inhibitor natrijum-glukoznog kotransportera tipa 2 – dapagliflozin u terapiji obolelih od diabetes mellitus tipa 2

Medicinski glasnik

Faktori rizika za krvarenje iz akutne mukozne lezije kod politraumatizovanih i kritično obolelih

Ustanova
KBC “Dr Dragiša Mišović”
Gradski zavod za hitnu pomoć, Beograd
Klinika za hirurgiju Urgentnog centra KCS
Reference
Barkun AN, Bardou M, Pham CQ, Martel M. Proton pump inhibitors vs histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis. Am J Gastroenterol 2012; 107: 507–520.
Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med 2013; 41: 693–705.
Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 58
Sažetak

Faktori rizika za krvarenje iz akutne mukozne lezije kod politraumatizovanih i kritično obolelih

Medicinski glasnik